Reflector is Pharm Exec's Brussels correpsondent.


European Pricing Talks: A lot of Smoke—or is it Fire?

What to make of the simmering public and political angst

New Flare-Up in Europe's External Reference Pricing Debate

European industry fights over every inch on comparative drug pricing initiative.

Health Technology’s Double-Edged Sword

Europe slow to action on emerging technologies, but the complex issues clouding EHRs and gene editing, for example, offer pause.

Is This When the Drug Industry Starts a Fight-Back?

“You wanna play rough? Just try it!” was the gist of the New-Year message from the European pharma industry to the healthcare authorities circling around drug firms preparing for pricing discussions. Reflector reports.